Tel Aviv / Zurich, December 17, 2020 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) ("SHL” or the “Company”), a leading provider and developer of advanced personal telemedicine solutions, announced…
Tel Aviv / Zurich, December 15, 2020 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) ("SHL”), a leading provider and developer of advanced personal telemedicine solutions, announced today that its…
Tel Aviv / Zurich, 10 December 2020 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL” or the “Company”), a leading provider and developer of advanced personal telemedicine solutions, today…
Tel Aviv / Zurich, 1 December, 2020 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN), a leading provider and developer of advanced personal telemedicine solutions, today announced that its German…
Tel Aviv / Zurich, 5 November 2020 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL” or the “Company”), a leading provider and developer of advanced personal telemedicine solutions, today…
Prediction of future life-threatening cardiac events based on SHL ECG devices, including SmartHeart™ technology, enabling performing a remote full 12 Lead ECG by any person Tel Aviv / Zurich, 2…
Study intends to evaluate the use of home telemonitoring SmartHeart technology to decrease hospital visits and lower healthcare utilization costs. Tel Aviv / Zurich / Newton MA, 14 October 2020…
Tel Aviv / Zurich, 8 October 2020 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL” or the “Company”), a leading provider and developer of advanced personal telemedicine solutions, today…
Tel Aviv / Zurich, 25 September 2020 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL”), a leading provider and developer of advanced personal telemedicine solutions, announced today the results…